Ginger as an adjuvant for chemotherapy-induced nausea and vomiting: where does the evidence stand?

Wolfgang Marx, Karin Ried, Daniel Mckavanagh, Luis Vitetta, Avni Sali, Liz Isenring

Research output: Contribution to journal › Meeting Abstract › Research › peer-review

Abstract

Despite advances in anti-emetic therapy, chemotherapy-induced nausea and vomiting (CINV) still poses a significant burden to patients undergoing chemotherapy. Nausea, in particular, is still highly prevalent in this population. Ginger has been traditionally used as a remedy for gastrointestinal complaints and has been suggested as a viable adjuvant treatment for nausea and vomiting in the cancer context.
Original languageEnglish
Article number735
Pages (from-to)115-116
Number of pages2
JournalAsia-Pacific Journal of Clinical Oncology
Volume10
Issue numberSupp S9
DOIs
Publication statusPublished - Dec 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

Fingerprint

Dive into the research topics of 'Ginger as an adjuvant for chemotherapy-induced nausea and vomiting: where does the evidence stand?'. Together they form a unique fingerprint.
View full fingerprint

  • Oncology Nutrition Research

    Isenring, E. (Project Lead), Marshall, S. (Senior Research Fellow), Van der Meij, B. (Senior Research Fellow), Rigby, R. (Associate Investigator), Teleni, L. (HDR Student), Crichton, M. (HDR Student) & Tang, X. (Admin)

    1/01/14 → …

    Project: Research

Cite this